In this sense, the same group demonstrated significantly increased levels of complement proteins in GLAST+ EVs from AD patients compared to controls, which could potentially damage neurons in the advanced inflammatory stage of AD [97]. The gene discussed is VTN; the disease is Alzheimer disease.